MEDTRONIC PUERTO RICO OPERATIONS CO. SYNCHROMED II; PUMP, INFUSION, IMPLANTED, PROGRAMMABLE
|
Back to Search Results |
|
Model Number 8637-40 |
Device Problem
Excess Flow or Over-Infusion (1311)
|
Patient Problems
Headache (1880); Incontinence (1928); Muscle Weakness (1967); Numbness (2415)
|
Event Date 02/03/2023 |
Event Type
Injury
|
Event Description
|
Information was received from multiple sources (manufacturer representative, healthcare provider, foreign) regarding a patient who w as receiving lioresal (baclofen) with concentration 2000 mcg/ml via an implantable pump for unknown indications for use.Other medications (oral, etc.) the patient was taking at the time of the event was unable to be obtained.The patient's medical history included multiple sclerosis.It was reported that the patient experienced intrathecal baclofen pump overdose three days post implant.A call was received from a healthcare provider on (b)(6) 2023 to advise regarding patient discharge home after implant on (b)(6) 2023.It was indicated that 3 days post op (b)(6) 2023, the patient had been admitted to hospital with headache, urinary incontinence, lower limb weakness, and numbness.A spinal scan was completed and findings were normal.Interventions taken included investigations and reduction of baclofen dose.The lioresal (concentration 2000mcg/ml) dose rate of 150 mcg/day was reduced over time.No surgical intervention occurred and no surgical intervention was planned.The patient was now currently on a minimum dose rate and all symptoms had resolved.There were no known factors that may have led or contributed to the issue.The issue was resolved as of (b)(6) 2023.The patient was without injury regarding their status as of (b)(6) 2023.The patient's age at the time of the event was 49 years and 10 months.The patient's weight at the time of the event was unknown.
|
|
Manufacturer Narrative
|
Concomitant medical products: product id: 8780, lot# 0224626681, implanted: (b)(6) 2023, product type: catheter.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Search Alerts/Recalls
|
|
|